Abstract
A major goal of molecular testing is to develop a cost-effective as well as sensitive and specific assay that can detect microbial DNA in clinical samples early in the course of disease. Additionally, the ability to analyze the genetic relatedness of fungi on a timelier basis using molecular methods will have a positive impact on epidemiologic investigating. As technology advances, it seems apparent that commercially available molecular assays will become available in the near future for the management of patients with suspected fungal infections.
Original language | English (US) |
---|---|
Pages (from-to) | 781-799 |
Number of pages | 19 |
Journal | Clinics in Laboratory Medicine |
Volume | 23 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2003 |
ASJC Scopus subject areas
- Clinical Biochemistry
- Biochemistry, medical